About METASTAT INC
Sector
Industry
CEO
Douglas A. Hamilton
Website
Headquarters
Boston
Founded
2009
ISIN
US59140A2033
FIGI
BBG000V8ZL66
MetaStat, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes MetaSite Breast and MenaCalc platforms. The MetaSite Breast test measures the process of systemic metastasis and is intended for early stage breast cancer patients. The MenaCalc, a platform of diagnostic assays, based on the measurement of the balance of the Mena protein isoforms, is broadly applicable in solid epithelial-based cancers, including breast, prostate, lung and colorectal. The company was founded by Warren C. Lau in July 2009 and is headquartered in Boston, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MTST is 0.000100 USD — it has increased by 9.90 K% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange METASTAT INC stocks are traded under the ticker MTST.
METASTAT INC is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
MTST stock is 99.00% volatile and has beta coefficient of 0. Check out the list of the most volatile stocks — is METASTAT INC there?
Yes, you can track METASTAT INC financials in yearly and quarterly reports right on TradingView.
No, MTST doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MTST shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade METASTAT INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So METASTAT INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating METASTAT INC stock shows the sell signal. See more of METASTAT INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.